Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
For the three years preceding the Bridge launch, a parallel market for GLP-1 medications had been providing actual price competition for Novo Nordisk and Eli Lilly via compounding pharmacies operating under FDAs 503A and 503B framework
Discovering a nodule while taking tirzepatide is almost certainly coincidental, not causal, particularly given that thyroid ultrasound has become more common in recent years, leading to more incidental nodule detection in all populations
Avg weight loss (72 weeks): ~19.5% (SURMOUNT-1) 15 mg Weeks 21+ Maximum dose
Who it fits: Patients who need cognitive performance support during a physical recovery cycle, or who want to address both systems simultaneously
Oral GLP-1s and New Formulations: The December 2025 approval of oral semaglutide (Wegovy pill) and the anticipated approval of orforglipron (Eli Lilly's non-peptide oral GLP-1) in 2026 will expand the patient pool significantly
There are many other supportive supplements and lifestyle options to help reduce fibroid growth
US$ 21.30
US$ 27.14
US$ 21.85
US$ 25.00
US$ 28.96
